Noel T. Southall, Ph.D.

Affiliations: 
2001 University of California, San Francisco, San Francisco, CA 
Area:
protein folding and stability
Google:
"Noel Southall"
Mean distance: 9.43
 

Parents

Sign in to add mentor
Ken A. Dill grad student 2001 UCSF
 (Insights on the hydrophobic effect in a simple model of water.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Moritz AE, Free RB, Weiner WS, et al. (2020) Discovery, Optimization and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist. Journal of Medicinal Chemistry
Zhou H, Blevins MA, Hsu JY, et al. (2020) A SIX1/EYA2 small molecule inhibitor disrupts EMT and metastasis. Cancer Research
Dextras C, Dashnyam M, Griner LAM, et al. (2020) Identification of Small Molecule Enhancers of Immunotherapy for Melanoma. Scientific Reports. 10: 5688
Kapoor A, Ghosh AK, Forman M, et al. (2020) Validation and characterization of five distinct novel inhibitors of human cytomegalovirus. Journal of Medicinal Chemistry
Sheils T, Mathias SL, Siramshetty VB, et al. (2020) How to Illuminate the Druggable Genome Using Pharos. Current Protocols in Bioinformatics. 69: e92
Shah P, Siramshetty VB, Zakharov AV, et al. (2020) Predicting liver cytosol stability of small molecules Journal of Cheminformatics. 12
Kaftanovskaya EM, Ng HH, Soula M, et al. (2019) Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201901046R
Huang R, Grishagin I, Wang Y, et al. (2019) The NCATS BioPlanet - An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics. Frontiers in Pharmacology. 10: 445
Sengupta N, Jović M, Barnaeva E, et al. (2019) A large scale high throughput screen identifies chemical inhibitors of phosphatidylinositol 4-kinase type II alpha. Journal of Lipid Research
Chiang N, Barnaeva E, Hu X, et al. (2018) Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions. Cell Chemical Biology
See more...